Saturday, October 22, 2016 — Manhattan
* * *
He saw the glow before she sat down.
The restaurant was Atomix — a tasting counter in a townhouse on East 30th, quiet, precise, the kind of place that served twelve courses and expected you to pay attention.
He’d booked the private dining room upstairs: six seats, warm wood, a single window looking onto a garden that was losing its leaves.
He’d arrived twenty minutes early because twenty minutes was the minimum lead time required to read a room, select the right chair, and be settled when the other party arrived.
She walked in at eight-oh-two.
Black dress.
Not a gown — a fitted Diane von Furstenberg wrap in matte black jersey that crossed at the chest and tied at the waist and showed the full shape of her body without exposing skin.
Long sleeves, hem above the knee.
Black patent Saint Laurent pumps, pointed toe, slim heel that put her at six one.
Her hair was down — the honey-gold waves, thicker than they’d been two weeks ago, catching the candlelight.
Diamond studs.
No other jewellery.
She looked different.
The glow serum.
It had restructured her moisture barrier in fifteen days, which was three days ahead of the timeline he’d projected.
Her skin had a quality that the candlelight made obvious — dewy, glassy, a wet sheen across her cheekbones and the bridge of her nose that wasn’t makeup or highlighter.
It was the skin itself, the surface so smooth and hydrated that it looked like she’d pressed a damp cloth to her face and the moisture had fused with her pores and refused to leave.
Glass skin — the Korean term for it, except no Korean routine produced this.
This was structural.
She looked ripe.
There was no other word for it.
The skin, the hair, the way the wrap dress clung to breasts that were already sitting higher on her chest — the breast firming was ahead of schedule too.
Two weeks in, and the Cooper’s ligaments were responding faster than any test subject he’d modelled, because she was twenty-eight and healthy and her tissue had the elasticity of a body that hadn’t started to decline.
She sat across from him and crossed her legs and the hem of the wrap dress shifted above her knee, showing a length of thigh that was bare and smooth and faintly golden in the candlelight, and he catalogued every detail the way he catalogued data — without sentiment, with precision, with the awareness that the woman sitting across from him was being transformed by his science and didn’t yet understand the scale of what that meant.
“You look different,” he said.
“I know.”
She set her phone face-down on the table.
A tell — she did this when she wanted to focus.
He’d noted it from the first dinner.
“How much of this is real?” she asked.
“Define real.”
“Not placebo.
Not expectation bias.
Not the fact that I’ve been sleeping better because my skin doesn’t feel like it’s drying out overnight.”
“What are you seeing?”
She told him.
Clinical, precise — the language of a woman who processed information through quantification and comparison.
Skin texture: finer, pores reduced, lines at the right eye softer.
Breast firmness: measurable improvement, upper pole fuller, décolleté tighter.
Body hair: complete cessation of regrowth in all treated areas, now twelve days since last shave with zero visible follicular activity.
Hair: faster growth, visibly thicker, improved lustre.
Glow: present, visible, confirmed by a third party — her analyst, unprompted.
“All of it,” he said.
“All of it is real.”
“How?”
“The anti-aging serum targets the fibroblasts in the dermal layer — the cells that produce collagen and elastin.
Standard retinoids signal those cells to work harder.
This serum changes the cells themselves.
It resets their production cycle to peak output.
Not a stimulus — a reprogramming.”
“Reprogramming.”
“The same way your body programmed those cells during puberty.
The serum reactivates that developmental pathway.
Your skin isn’t being maintained — it’s being rebuilt.”
She picked up her glass — sparkling water, not champagne — and drank.
Her hand was steady.
Her eyes were not.
They were moving the way they moved when she was processing a pitch — scanning his face, checking for tells, looking for the data that didn’t match the thesis.
“The hair prevention.
How is that permanent in two weeks?”
“The compound targets the dermal papilla — the structure at the base of each hair follicle that sends growth signals.
Terminal hair has an active growth phase that cycles.
The compound doesn’t inhibit the cycle — it shuts down the papilla.
No signal, no growth.
The follicle remains intact but dormant.”
“And scalp hair is unaffected.”
“The compound is receptor-specific.
Scalp follicles, brows, and lashes have a different receptor profile.
The compound doesn’t bind to them.”
“What about the breast firming?
I’ve seen surgical results that are less dramatic than what I’m seeing after two weeks.”
“Cooper’s ligaments.
The structural framework that holds breast tissue in position.
They’re made of collagen — they stretch over time, from gravity, from movement, from age.
The compound stimulates new collagen deposition within the ligament structure while crosslinking the existing fibres.
The effect is a tissue that becomes denser and more supportive.
Not a lift — a rebuild.”
“You’re describing tissue engineering.”
“Yes.”
“Done with a topical cream.”
“Done with a compound that penetrates to the fascial layer.
The delivery system is as important as the active ingredient.
Standard cosmetics sit on the stratum corneum — the dead outer layer.
My formulations reach the dermis and the deep fascia.
That’s why they work.”
She was quiet for a moment.
The first course arrived — a single oyster with a cucumber foam and a dot of wasabi oil.
She ate it.
He ate his.
The chef withdrew.
“I Googled you,” she said.
“I know.”
“You published seven papers at Stanford.
All in the same fields — dermal collagen, follicular biology, structural tissue.
You were doing this research in the open.”
“I was building the foundation.”
“Then you left.
Your faculty page is a 404.
Your patents after 2015 are filed through an entity in Vaduz.
No listed directors, no website, no public filings.”
“Correct.”
“Why?”
“Because the science exceeded what a university could contain.
Stanford would have wanted publications, peer review, licensing agreements with L’Oréal or Procter & Gamble.
I needed control.”
“Of the science.”
“Of everything.”
She leaned back.
The wrap dress shifted and the V at her chest opened a centimetre and he could see the inner curve of her right breast, the skin smooth and dewy in the candlelight, the glow serum giving her décolleté a wet-glass finish that two weeks ago hadn’t been there.
“Tell me about the business,” she said.
“Not yet.”
“You promised me a hundred-billion-dollar company.”
“I promised you six weeks.
You’re at two.”
“I’m at two weeks and I can already see that whatever you’ve formulated is beyond anything on the market.
I’m not a chemist but I trade biotech and I know what’s in the pipeline at every major skincare company on the planet, and nothing — nothing — does what these products do.
So either you’re the most advanced formulation chemist alive or you’ve got access to something nobody else has.”
“Both.”
She stared at him.
He let her.
“I’m not going to tell you what that something is,” he said.
“Not now.
Not at week two.
At week six, I’ll show you the vision — the company, the structure, the market, the trajectory.
And then you’ll decide.”
“Decide what?”
“Whether you want to run it.”
She blinked.
A single, involuntary contraction that told him more than any sentence she’d spoken.
She hadn’t expected that.
She’d expected investor, partner, advisor, board seat.
She hadn’t expected the wheel.
“Run it.”
“CEO.
Your name.
Your face.
Your structure.
I provide the science.
You build the machine.”
The second course arrived.
They ate in silence.
He watched her process — the way her jaw worked when she was chewing and thinking simultaneously, the way her eyes went distant and then snapped back.
“I have questions,” she said.
“Save them.”
“Four more weeks.”
“Four more weeks.”
She picked up her water and drank and set the glass down with a precision that told him she was controlling the impulse to push harder, and the control was costing her, and the cost was part of the process.
She was a woman who ran toward answers.
He was asking her to wait.
The meal lasted two hours.
Twelve courses.
They talked about her fund — her positions, her thesis on biotech valuations, the trade she was building in a logistics company that nobody else had noticed.
He asked the questions that showed he’d done the homework and she answered them the way she answered LP questions — with data and edges and the occasional flash of wit that made her dangerous.
He didn’t touch her.
He didn’t compliment her body or her skin or the way the candlelight caught the glow on her cheekbones.
He kept the conversation clinical, professional, precise — the language of two people who understood that what was being negotiated was bigger than dinner and more dangerous than attraction.
When the meal ended, he stood.
Charcoal cashmere against candlelight, the sweater pulling across his chest.
She looked at his arms — the forearms, the veins — and caught herself looking and looked away.
“Good night, Eliana.”
He left first.
Through the private room, down the narrow stairs, into the October night.
The air was cold and tasted like rain.
His thumb found the ring.
On.
* * * ENCOUNTER LOG — ELIANA ROTH (#3)
Compatibility index: 0.94 → 0.96
Product efficacy: AHEAD OF PROJECTED TIMELINE
Conversion probability: 0.91 * * *
He dismissed the log and walked east.
Twenty blocks to the penthouse.
The deficit warning pulsed red and he felt it in his blood — the restlessness, the appetite, the six months of celibacy compressed into a pressure that spiked every time he sat across from her and didn’t touch her.
He crossed Park Avenue against the light and a taxi honked and he didn’t look.